Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic
In this episode, James Hamet at Vistim Labs and Duane Mancini discuss licensing technology from a university, voice of customer, neurodegenerative diseases, the importance of your economic story, why they are focusing on clinical data, and so much more.
Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic
In this episode, James Hamet at Vistim Labs and Duane Mancini discuss licensing technology from a university, voice of customer, neurodegenerative diseases, the importance of your economic story, why they are focusing on clinical data, and so much more.